Brief: ViroGates Announces Agreement With SOBI
June 2 (Reuters) - ViroGates A/S VIROG.CO :
* AGREEMENT WITH SOBI
* AGREEMENT FOR DEVELOPMENT OF SUPARNOSTICFOR COMMERCIAL USE
IN US
IN COMBINATION WITH SOBI’S KINERET TREATMENT FOR
COVID-19-RELATED PNEUMONIA
* PARTIES WILL NOT DISCLOSE FINANCIAL ASPECTS OF AGREEMENT
* AGREEMENT WILL NOT HAVE IMPLICATIONS FOR VIROGATES’
FINANCIAL
EXPECTATIONS FOR 2023
Source text for Eikon: ID:
Further company coverage: VIROG.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))